Not Yet RecruitingNot Applicable

Endoscopic Pancreatic Duct Stent Placement Versus Conventional Approach in the Treatment of Early Phase Acute Pancreatitis

China, Russia200 participantsStarted 2025-09-01

Plain-language summary

The planned multicenter randomized study is aimed to assess the efficacy and safety of endoscopic pancreatic duct stenting in adult patients with acute pancreatitis. It is planned to include patients with early-stage nonbiliary pancreatitis in the study.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Diagnosis of acute pancreatitis confirmed on the basis of at least 2 of the 3 diagnostic criteria according to the revised Atlanta classification
✓. Presence of organ failure signs (moderate and severe pancreatitis)
✓. Informed consent of the patient

Exclusion criteria

✕. Presence of other indications for endoscopic intervention on the major duodenal papilla (biliary pancreatitis with cholangitis, calculus of the major duodenal papilla, stenosis of the major duodenal papilla, etc.)
✕. Previous surgical interventions on the major duodenal papilla
✕. Diverticula of the major duodenal papilla
✕. Pregnancy
✕. Shock
✕. Coagulopathy (INR\>1.5, blood platelets \< 50\*109/l

What they're measuring

Mortality rate

Timeframe: From enrollment to the end of treatment at 3 months

Trial details

NCT IDNCT07093996

SponsorAlmazov National Medical Research Centre

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-12-01

Contact for this trial

Pavel A Kotkov, MD

89062619231 Kotkovdr@mail.ru

View on ClinicalTrials.gov More Acute Pancreatitis (AP) trials